Fehr Gordon J. 4/A
4/A · MERRIMACK PHARMACEUTICALS INC · Filed May 1, 2012
Insider Transaction Report
Form 4/AAmended
Fehr Gordon J.
Director
Transactions
- Exercise/Conversion
Common Stock
2012-04-17$2.19/sh+5,462$11,962→ 170,143 total - Exercise/Conversion
Stock Option (right to buy)
2012-04-17−5,462→ 0 totalExercise: $2.19Exp: 2012-05-03→ Common Stock (5,462 underlying)
Footnotes (2)
- [F1]This option is fully vested.
- [F2]The original Form 4 inadvertently listed the exercise of this option as an acquisition, as opposed to a disposition.